FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2148111882> ?p ?o ?g. }

• W2148111882 endingPage "6391" @default.
• W2148111882 startingPage "6383" @default.
• W2148111882 abstract "Highly pathogenic avian influenza A virus (H5N1) is a leading candidate for the next influenza pandemic, and infants and children may play an important role in transmission in a pandemic. Our objective was to evaluate the safety and immunogenicity of a prototype inactivated, aluminium adjuvanted, split-virus, clade 1 H5N1 vaccine (A/Vietnam/1194/2004/NIBRG-14) in infants and children aged > or =6 months to < 9 years.Healthy infants and children (N=150) received two doses of 30 microg or 45 microg H5 HA with AlPO4 adjuvant 21 days apart. Serum samples were collected for virus microneutralisation (MN) and haemagglutination inhibition (HI) assays on Days 0, 21, and 42. Six-month antibody persistence following second vaccine dose was assessed by MN, and cross-reactive HI antibodies to a clade 2 variant strain (INDO5/RG2) were evaluated at Day 42.Both formulations were well-tolerated. Two doses of 30 microg or 45 microg H5 HA formulations elicited strong immune responses by both MN (98-99% > or =1:20) and HI assays (95-100% > or =1:32), with 80-87% of children having MN antibody persistence (> or =1:20) up to 6 months post-vaccination. Additionally, robust cross-clade HI antibody responses were elicited following two doses.Two doses of prototype 30 microg or 45 microg aluminium-adjuvanted, H5N1 vaccines were highly immunogenic and well-tolerated, with considerable antibody persistence 6 months after the primary vaccination course. Additional cross-clade HI antibody responses and an acceptable safety and tolerability profile support the use of the either candidate vaccine formulations in infants and children in the event of a pandemic." @default.
• W2148111882 created "2016-06-24" @default.
• W2148111882 creator A5000523306 @default.
• W2148111882 creator A5010711854 @default.
• W2148111882 creator A5014301435 @default.
• W2148111882 creator A5017199045 @default.
• W2148111882 creator A5024597692 @default.
• W2148111882 creator A5025719691 @default.
• W2148111882 creator A5029956713 @default.
• W2148111882 creator A5030667842 @default.
• W2148111882 creator A5038228333 @default.
• W2148111882 creator A5055194670 @default.
• W2148111882 creator A5069155052 @default.
• W2148111882 creator A5079961950 @default.
• W2148111882 creator A5085733706 @default.
• W2148111882 date "2008-11-01" @default.
• W2148111882 modified "2023-10-18" @default.
• W2148111882 title "Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children" @default.
• W2148111882 cites W104959878 @default.
• W2148111882 cites W1795974608 @default.
• W2148111882 cites W1965570435 @default.
• W2148111882 cites W1967449698 @default.
• W2148111882 cites W1972452580 @default.
• W2148111882 cites W1990429464 @default.
• W2148111882 cites W2010866755 @default.
• W2148111882 cites W2011879952 @default.
• W2148111882 cites W2015795623 @default.
• W2148111882 cites W2018151048 @default.
• W2148111882 cites W2031993383 @default.
• W2148111882 cites W2044678758 @default.
• W2148111882 cites W2047562582 @default.
• W2148111882 cites W2059316621 @default.
• W2148111882 cites W2068553244 @default.
• W2148111882 cites W2075632360 @default.
• W2148111882 cites W2089572756 @default.
• W2148111882 cites W2108273817 @default.
• W2148111882 cites W2109283527 @default.
• W2148111882 cites W2111943979 @default.
• W2148111882 cites W2114555019 @default.
• W2148111882 cites W2115130267 @default.
• W2148111882 cites W2118110185 @default.
• W2148111882 cites W2121708957 @default.
• W2148111882 cites W2122096836 @default.
• W2148111882 cites W2122798802 @default.
• W2148111882 cites W2124979957 @default.
• W2148111882 cites W2142240784 @default.
• W2148111882 cites W2145531750 @default.
• W2148111882 cites W2148882065 @default.
• W2148111882 cites W2151926553 @default.
• W2148111882 cites W2155467153 @default.
• W2148111882 cites W2163401540 @default.
• W2148111882 cites W2441850575 @default.
• W2148111882 doi "https://doi.org/10.1016/j.vaccine.2008.08.046" @default.
• W2148111882 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18801398" @default.
• W2148111882 hasPublicationYear "2008" @default.
• W2148111882 type Work @default.
• W2148111882 sameAs 2148111882 @default.
• W2148111882 citedByCount "80" @default.
• W2148111882 countsByYear W21481118822012 @default.
• W2148111882 countsByYear W21481118822013 @default.
• W2148111882 countsByYear W21481118822014 @default.
• W2148111882 countsByYear W21481118822015 @default.
• W2148111882 countsByYear W21481118822017 @default.
• W2148111882 countsByYear W21481118822018 @default.
• W2148111882 countsByYear W21481118822019 @default.
• W2148111882 countsByYear W21481118822020 @default.
• W2148111882 countsByYear W21481118822021 @default.
• W2148111882 countsByYear W21481118822022 @default.
• W2148111882 crossrefType "journal-article" @default.
• W2148111882 hasAuthorship W2148111882A5000523306 @default.
• W2148111882 hasAuthorship W2148111882A5010711854 @default.
• W2148111882 hasAuthorship W2148111882A5014301435 @default.
• W2148111882 hasAuthorship W2148111882A5017199045 @default.
• W2148111882 hasAuthorship W2148111882A5024597692 @default.
• W2148111882 hasAuthorship W2148111882A5025719691 @default.
• W2148111882 hasAuthorship W2148111882A5029956713 @default.
• W2148111882 hasAuthorship W2148111882A5030667842 @default.
• W2148111882 hasAuthorship W2148111882A5038228333 @default.
• W2148111882 hasAuthorship W2148111882A5055194670 @default.
• W2148111882 hasAuthorship W2148111882A5069155052 @default.
• W2148111882 hasAuthorship W2148111882A5079961950 @default.
• W2148111882 hasAuthorship W2148111882A5085733706 @default.
• W2148111882 hasConcept C126322002 @default.
• W2148111882 hasConcept C159047783 @default.
• W2148111882 hasConcept C159654299 @default.
• W2148111882 hasConcept C182072434 @default.
• W2148111882 hasConcept C197934379 @default.
• W2148111882 hasConcept C203014093 @default.
• W2148111882 hasConcept C22070199 @default.
• W2148111882 hasConcept C2522874641 @default.
• W2148111882 hasConcept C2776872762 @default.
• W2148111882 hasConcept C2777546802 @default.
• W2148111882 hasConcept C2777863537 @default.
• W2148111882 hasConcept C2778375690 @default.
• W2148111882 hasConcept C2780868878 @default.
• W2148111882 hasConcept C32611913 @default.
• W2148111882 hasConcept C519248777 @default.
• W2148111882 hasConcept C71924100 @default.

• next